Adverse Effect Labeling
Adverse Effect Labeling is a regulatory documentation requirement that specifies the systematic disclosure of potential harmful reactions associated with a pharmaceutical product, distinguished by its focus on identifying, characterizing, and communicating clinically significant adverse events in labeling to inform healthcare providers and patients.
9
Publications
419
Citations
46
Authors
26
Institutions
Publications per year
2017–2026
1
9
Cindy G. Grappe, Cindy Lombart, Didier Louis et al. · Journal of Retailing and Consumer Services · 2022 · 41 citations · Full text
1–5 of 9
46
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 46
26
Creighton University
Omaha, United States
1 h-index
2 publications
50 citations

University of Wolverhampton
Wolverhampton, United Kingdom
1 h-index
2 publications
130 citations

Brigham and Women's Hospital
Boston, United States
1 h-index
1 publications
26 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
1 h-index
1 publications
19 citations
CHI Health Immanuel
Omaha, United States
1 h-index
2 publications
50 citations
NHS Lothian
Edinburgh, United Kingdom
1 h-index
1 publications
149 citations

University of Alberta
Edmonton, Canada
1 h-index
1 publications
41 citations
Université du Québec à Montréal
Montreal, Canada
1 h-index
2 publications
82 citations
1–8 of 26
1 publications · 149 citations
1
h-index
AJHP · 1 publications · 16 citations
1
h-index
1 publications · 25 citations
1
h-index
1 publications · 66 citations
1
h-index
1 publications · 65 citations
1
h-index
1–5